CV Sciences (CVSI) Operating Expenses (2011 - 2026)
CV Sciences (CVSI) reported Operating Expenses of $1.9 million for Q1 2026, up 89.9% on a YoY basis from $990000.0 in Q1 2025, and up 169.04% sequentially from -$2.7 million in Q4 2025.
CV Sciences (CVSI) Operating Expenses (2011 - 2026) Analysis & Trends
CV Sciences (CVSI) has 16 years of Operating Expenses data on file, last reported at $1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 89.9% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (down 54.24% YoY), and the FY2025 full-year result was $3.3 million, down 65.0% from the prior year.
- Operating Expenses climbed to $1.9 million in Q1 2026, from -$2.7 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $3.7 million in Q4 2022 to a low of -$3.4 million in Q4 2023.
- A 5-year average of $1.7 million and a median of $2.3 million in 2023 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses surged 168.85% in 2024 and plunged 217.22% in 2025, its largest moves.
- Tracing CVSI's Operating Expenses over 5 years: stood at $3.7 million in 2022, then slumped by 191.51% to -$3.4 million in 2023, then jumped by 168.85% to $2.3 million in 2024, then sank by 217.22% to -$2.7 million in 2025, then jumped by 169.04% to $1.9 million in 2026.
- Business Quant data shows CVSI's Operating Expenses at $1.9 million in Q1 2026, -$2.7 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.88 Mn |
| Dec 31, 2025 | -2.72 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Mar 31, 2025 | 990,000.00 |
| Dec 31, 2024 | 2.32 Mn |
| Sep 30, 2024 | 769,000.00 |
| Jun 30, 2024 | 2.44 Mn |
| Mar 31, 2024 | 2.47 Mn |
| Dec 31, 2023 | -3.37 Mn |
| Sep 30, 2023 | 2.28 Mn |
| Jun 30, 2023 | 2.79 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | 3.69 Mn |
| Sep 30, 2022 | 2.45 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | 2.67 Mn |
| Dec 31, 2021 | 10.45 Mn |
| Sep 30, 2021 | 5.34 Mn |
| Jun 30, 2021 | 5.80 Mn |